Annual report pursuant to Section 13 and 15(d)

Document And Entity Information

v3.21.1
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2020
Mar. 15, 2021
Jun. 30, 2020
Document Information Line Items      
Entity Registrant Name RELMADA THERAPEUTICS, INC.    
Document Type 10-K    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   16,745,930  
Entity Public Float     $ 694,982,670
Amendment Flag false    
Entity Central Index Key 0001553643    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Dec. 31, 2020    
Document Fiscal Year Focus 2020    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity File Number 000-55347    
Entity Incorporation, State or Country Code NV    
Entity Interactive Data Current Yes